Aspira Women's Health Inc. (AWH )

Currency in USD Disclaimer
$0.15 +$0.01 (9.71%)
Closed 03/13/2025
$0.13
$0.16
$0.12
$3.81

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol AWH
  • Company Aspira Women's Health Inc.
  • Price $0.15
  • Changes Percentage 9.71
  • Change 0.0136
  • Day Low $0.13
  • Day High $0.16
  • Year High $3.81
  • Year Low $0.12
  • Market Cap $2,714,880
  • Price Avg 50 EMA (D) $0.38
  • Price Avg 200 EMA (D) $0.93
  • Exchange NASDAQ
  • Volume 4,477,943
  • Average Volume 3,815,566
  • Open $0.13
  • Previous Close $0.14
  • EPS -1.15
  • PE -0.13
  • Earnings Announcement 2025-03-26 12:30:00
  • Shares Outstanding $17,675,000

Company brief: ASPIRA WOMEN'S HEALTH INC. (AWH )

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.

AWH Corporation News

Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes

Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes

March 11, 2025 at 12:00 pm ET

accessnewswire.com -- AUSTIN, TX / ACCESS Newswire / March 11, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecol...

Income Statement